562 results on '"Bonin, Serena"'
Search Results
2. Comparative Analysis of Gene Expression Analysis Methods for RNA in Situ Hybridization Images
3. Impact of standardization in tissue processing: the performance of different fixatives
4. Baggio–Yoshinari Syndrome: A Report of Five Cases.
5. The Use of Paraffin Blocks/Pathology Archives for Clinical Biobanking
6. Evaluation of a New DNA Extraction Method on Challenging Bone Samples Recovered from a WWII Mass Grave
7. Molecular diagnostics of prostate cancer: impact of molecular tests
8. In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells
9. Cell-stiffness and morphological architectural patterns in clinical samples of high grade serous ovarian cancers
10. Comparative Analysis of Gene Expression Analysis Methods for RNA in SituHybridization Images
11. Retrospective Analysis of Potential Lyme Disease Clinical Cases in Argentina.
12. Quantifying mRNA in Highly Degraded Fixed Tissues by Nanostring Technology: A Comparative Study.
13. Pre-analytics and tumor heterogeneity
14. Comparative Analysis of Gene Expression Analysis Methods for RNA In Situ Hybridization Images
15. Unraveling the Complex Nexus of Human Papillomavirus (HPV) in Extragenital Keratinocyte Skin Tumors: A Comprehensive Analysis of Bowen’s Disease and In Situ Squamous-Cell Carcinoma
16. Lyme Disease: A Review with Emphasis on Latin America
17. Interlaboratory evaluation of quality control methods for circulating cell-free DNA extraction
18. Pre-analytical processes in medical diagnostics: New regulatory requirements and standards
19. Giant melanoma of the abdomen: case report and revision of the published cases
20. Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers
21. Autoimmunity against a glycolytic enzyme as a possible cause for persistent symptoms in Lyme disease
22. Dermoscopic Findings in the Presurgical Evaluation of Basal Cell Carcinoma. A Prospective Study
23. Evaluation of a Set of miRNAs in 26 Cases of Fatal Traumatic Brain Injuries
24. The history of Lyme disease in Italy and its spread in the Italian territory
25. A group of three miRNAs can act as candidate circulating biomarkers in liquid biopsies from melanoma patients
26. Analysis of expression profiles of signalling and regulatory pathways in tumour tissues
27. Actinic Keratoses: A Prospective Pilot Study on a Novel Formulation of 4% 5-Fluorouracil Cream and a Review of Other Current Topical Treatment Options
28. The role of cutaneous human-papillomavirus (HPV) infection in in situ squamous cell carcinoma: a pilot study
29. Nanomechanical Characterization of Ovarian Cancer Cell Lines as a Marker of Response to 2c Treatment
30. Supplementary Figure 5 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
31. Supplementary Figure 4 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
32. Supplementary Table 1 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
33. Supplementary Data from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
34. The Baron Pasquale Revoltella’s Will in the Forensic Genetics Era
35. Supplementary Table 2 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
36. Supplementary Figure 1 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
37. Supplementary Figure 2 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
38. Supplementary Table 3 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
39. Supplementary Figure 6 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
40. Supplementary Figure 3 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
41. Substrate-dependent cell elasticity measured by optical tweezers indentation
42. The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients
43. Cutaneous melanoma frequencies and seasonal trend in 20 years of observation of a population characterised by excessive sun exposure
44. DNA Sequencing from PCR Products
45. Quantitative Real-Time RT-PCR
46. Nested-PCR
47. DNA Extraction from Formalin-Fixed Paraffin-Embedded (FFPE) Tissues
48. Reverse Transcription
49. Quantitative End-Point PCR
50. DNase Treatment of RNA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.